Press Releases

Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director of Roswell Park Comprehensive Cancer Center, has been appointed to the Transplantation, Tolerance and Tumor (TTT) Immunology Study Section within the National Institutes of Health (NIH) Center for Scientific Review.

Primary immunodeficiency diseases (PIDD) are a group of more than 300 disorders caused by single-gene defects that prevent the immune system from functioning properly. These immune disorders affect 1 in 1,200 people, and an association between these diseases and cancer has been noted.

An established hematology-oncology practice in the Buffalo Northtowns has capped a year of growth with an expansion and rebrand. Soniwala Hematology Oncology Associates, which has been part of the Roswell Park Comprehensive Cancer Center community cancer practice network since 2014, is now Roswell Park Hematology Oncology Northtowns

A group of retired firefighters dedicated to raising funds for cancer research visited Roswell Park Comprehensive Cancer Center today to make a significant donation that will go toward lung and prostate cancer research.

Roswell Park Comprehensive Cancer Center graduate student Danielle Twum has received the prestigious Emerging Scholars Award from the National Cancer Institute (NCI), recognizing her among the distinguished alumni of its Continuing Umbrella for Research Excellence (CURE) programs.

Sai Yendamuri, MD, FACS, Chair of the Department of Thoracic Surgery at Roswell Park Cancer Institute, received a prestigious award at a recent international gathering of thoracic surgeons.

Khurshid Guru, MD, one of the most experienced and accomplished robotic surgeons in the world, has been named Chair of the Department of Urology at Roswell Park Comprehensive Cancer Center. James Mohler, MD, has assumed the new role of Chief of Inter-Institutional Academics and will act as Roswell Park’s point person and liaison for translational research collaborations between Roswell Park and the University at Buffalo.

The Ride For Roswell, New York State’s largest single-day cycling fundraiser, concluded its 22nd year this weekend by raising a total of $4.6 million for cancer research and patient-care programs at Roswell Park Comprehensive Cancer Center.

A new study from Roswell Park Comprehensive Cancer Center reporting the findings of the first clinical trial to evaluate the immune effects of high-dose radiation therapy followed by surgery in patients with advanced kidney cancer may also set the stage for combination treatments with immunotherapy.